92 related articles for article (PubMed ID: 7295077)
1. Relationship between plasma concentration of middle molecular weight fraction b, motor nerve conduction velocity, and plasma creatinine in experimental chronic renal failure rats.
Boudet J; Man NK; Cueille G; Legrain Y; Funck-Brentano JL
Artif Organs; 1981; 4 Suppl():115-8. PubMed ID: 7295077
[No Abstract] [Full Text] [Related]
2. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
[TBL] [Abstract][Full Text] [Related]
3. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. I. Development of chronic renal failure in rats.
Onishi S; Okada S; Takasaki N
Bull Osaka Med Sch; 1986 Oct; 32(2):60-5. PubMed ID: 3427261
[No Abstract] [Full Text] [Related]
6. The peripheral nerve function in chronic renal failure. VI. The relationship betweeen sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy.
Nielsen VK
Acta Med Scand; 1973 Nov; 194(5):455-62. PubMed ID: 4757225
[No Abstract] [Full Text] [Related]
7. Experimental studies on pathogenesis and progression of uremic neuropathy in rats. II. Is plasma myoinositol a uremic neurotoxin?
Onishi S; Kawasaki T; Hamada K
Bull Osaka Med Sch; 1986 Oct; 32(2):66-72. PubMed ID: 3427262
[No Abstract] [Full Text] [Related]
8. [Nerve conduction velocity in chronic kidney failure].
Reichenmiller HE
Fortschr Med; 1973 Apr; 91(10):441-6. PubMed ID: 4633663
[No Abstract] [Full Text] [Related]
9. [Middle molecule level and myocardial contractility in kidney patients].
Dimitrakov D; Pisanets M
Vutr Boles; 1986; 25(2):18-20. PubMed ID: 3716372
[TBL] [Abstract][Full Text] [Related]
10. New biological method for determination of the desintoxication rate of human plasma after dialysis.
Kovatchev D; Dimitrov H; Hristova P; Nenov D
Life Support Syst; 1983; 1 Suppl 1():191-4. PubMed ID: 6336408
[No Abstract] [Full Text] [Related]
11. Remnant model of renal failure in the dog: avoidance of second surgery by chemical nephrectomy.
Fine A; Jones D; Kaushal G; LeGal Y; Sharma G
Clin Invest Med; 1990 Aug; 13(4):152-4. PubMed ID: 2208830
[TBL] [Abstract][Full Text] [Related]
12. Effects of protease therapy in the remnant kidney model of progressive renal failure.
Sebekova K; Paczek L; Dämmrich J; Ling H; Spustova V; Gaciong Z; Heidland A
Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
[TBL] [Abstract][Full Text] [Related]
13. Central sensory motor pathways are less affected than peripheral in chronic renal failure.
Kalita J; Misra UK; Rajani M; Kumar A
Electromyogr Clin Neurophysiol; 2004; 44(1):7-10. PubMed ID: 15008018
[TBL] [Abstract][Full Text] [Related]
14. Middle molecules evaluation in chronic renal failure during conservative treatment.
Severini G; Carta S; Taccone-Gallucci M; Mazzarella V; Iacona A; Meloni C; Casciani CU
Ann Ist Super Sanita; 1983; 19(2-3):417-9. PubMed ID: 6681233
[No Abstract] [Full Text] [Related]
15. Behavioral changes in the course of chronic renal insufficiency in rats.
Topczewska-Bruns J; Tankiewicz A; Pawlak D; Buczko W
Pol J Pharmacol; 2001; 53(3):263-9. PubMed ID: 11785927
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
17. Concentration of plasma middle molecular weight substances and clinical condition of patients undergoing short-time regular dialysis treatment.
Válek A; Dzúrik R; Spustová V; Válková D
Artif Organs; 1981; 4 Suppl():173-6. PubMed ID: 7295088
[TBL] [Abstract][Full Text] [Related]
18. [The development of chronic kidney failure in spontaneously hypertensive rats].
Barabanova VV; Titova VA; Miroshnichenko EL; Timoshenko TE
Biull Eksp Biol Med; 1993 Jun; 115(6):666-8. PubMed ID: 8374153
[TBL] [Abstract][Full Text] [Related]
19. The impact of chronic renal failure on nitric oxide synthase isoforms gene expression in the penis and pelvic ganglia of rats.
Abdel-Gawad M; Huynh H; Brock GB
J Urol; 1999 Oct; 162(4):1473-9. PubMed ID: 10492240
[TBL] [Abstract][Full Text] [Related]
20. Reduced aminolevulinic dehydrase activity with increased blood porphyrins in experimental chronic renal failure.
Fontanellas A; Torralbo A; Santos JL; Morán MJ; Barrientos A; Enríquez de Salamanca R
Exp Nephrol; 1997; 5(1):95-9. PubMed ID: 9052854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
